One hundred and fifteen falciparum and 25 vivax malaria patients who became ill at the Nam Ngum Dam construction site in Laos were treated with 3 treatment schedules.
Falciparum malaria patients usually responded excellently to 1500 mg or less of chloroquine base, but R 1 resistance was demonstrated in 4 Japanese and 1 Thai patients.
Sulformethoxine-pyrimethamine-quinine (SPQ) and sulformethoxine-pyrimethamine (SP) combination was effective in 18 of 18 and in 25 of 26 patients, respectively.
The febrile attack of 25 vivax malaria patients was successfully treated with any of chloroquine, SPQ and SP regimens. Weekly one SP tablet was sufficient to suppress both falciparum and vivax malarias among Japanese workers, 10 percent of which were attacked by falciparum malaria before prophylactic medication was started.
